99
Participants
Start Date
September 30, 2009
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
placebo
administered daily for 21 days
BCX4208
Administered daily for 21 days.
Altoona Center for Clinical Research, Duncansville
Arthritis & Osteoporosis Center of Maryland, Frederick
Triangle Medical Research Associates, Raleigh
Carolinas Center for Rheumatology & Arthritis, Rock Hill
Avail Clinical Research, DeLand
Anchor Research Center, Naples
Olive Branch Family Medical Center, Olive Branch
Kentucky Medical Research Center, Lexington
STAT Research, Dayton
Health Concepts, Rapid City
Bozeman Urgent Care Center, Bozeman
Medex Healthcare Research, St Louis
Heartland Clinical Research, Omaha
Lynn Health Science Institute, Oklahoma City
Renaissance Clinical Research, Dallas
Selah Medical Center, Boise
Radiant Research, Inc., Scottsdale
Catalina Pointe Clinical Research, Tucson
New Mexico Clinical Research & Osteoporosis Center, Albuquerque
Arthritis Center of Reno, Reno
San Diego Arthritis Medical Clinic, San Diego
Irvine Center for Clinical Research, Irvine
East-West Medical Research Institute, Honolulu
Northwest Clinical Research Center, Bellevue
Lead Sponsor
BioCryst Pharmaceuticals
INDUSTRY